193 related articles for article (PubMed ID: 10370949)
1. [Primary small cell carcinoma of the bladder].
Tiguert R; Ravery V; Gheiler EL; Grignon DJ; Gudziak MR; Wood DP; Pontes JE
Prog Urol; 1999 Apr; 9(2):256-60. PubMed ID: 10370949
[TBL] [Abstract][Full Text] [Related]
2. [Primary neuroendocrine carcinoma of the bladder: diagnosis and treatment].
Karmouni T; Rioux-Leclercq N; Bensalah K; Alva A; Patard JJ; Guillé F; Lobel B
Prog Urol; 2000 Sep; 10(4):590-4. PubMed ID: 11064903
[TBL] [Abstract][Full Text] [Related]
3. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience.
Choong NW; Quevedo JF; Kaur JS
Cancer; 2005 Mar; 103(6):1172-8. PubMed ID: 15700264
[TBL] [Abstract][Full Text] [Related]
4. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival.
Mackey JR; Au HJ; Hugh J; Venner P
J Urol; 1998 May; 159(5):1624-9. PubMed ID: 9554367
[TBL] [Abstract][Full Text] [Related]
5. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
Montie JE
J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778
[No Abstract] [Full Text] [Related]
6. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
7. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
Granfors T; Tomic R; Ljungberg B
Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
[TBL] [Abstract][Full Text] [Related]
8. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
9. Small cell carcinoma of the urinary bladder: a 15-year retrospective review of treatment and survival in the Anglian Cancer Network.
Mukesh M; Cook N; Hollingdale AE; Ainsworth NL; Russell SG
BJU Int; 2009 Mar; 103(6):747-52. PubMed ID: 19076139
[TBL] [Abstract][Full Text] [Related]
10. Treatment of muscle invasive bladder cancer. Is there a role for neoadjuvant chemotherapy?
Kuten A; Baz M; Rubinov R; Dale J; Haim N; Robinson E; Cohen Y
Strahlenther Onkol; 1994 Sep; 170(9):524-30. PubMed ID: 7524174
[TBL] [Abstract][Full Text] [Related]
11. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
Bex A; Nieuwenhuijzen JA; Kerst M; Pos F; van Boven H; Meinhardt W; Horenblas S
Urology; 2005 Feb; 65(2):295-9. PubMed ID: 15708041
[TBL] [Abstract][Full Text] [Related]
12. Can patient selection for bladder preservation be based on response to chemotherapy?
Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
14. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
[TBL] [Abstract][Full Text] [Related]
15. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients.
Cheng L; Pan CX; Yang XJ; Lopez-Beltran A; MacLennan GT; Lin H; Kuzel TM; Papavero V; Tretiakova M; Nigro K; Koch MO; Eble JN
Cancer; 2004 Sep; 101(5):957-62. PubMed ID: 15329903
[TBL] [Abstract][Full Text] [Related]
16. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
[TBL] [Abstract][Full Text] [Related]
17. Small cell carcinoma of the bladder: a case report and a literature review.
Dalpiaz O; al Rabi N; Galfano A; Martignoni G; Ficarra V; Artibani W
Arch Esp Urol; 2003 Mar; 56(2):197-202. PubMed ID: 12731451
[TBL] [Abstract][Full Text] [Related]
18. Clinical review - small cell carcinoma of the bladder.
Church DN; Bahl A
Cancer Treat Rev; 2006 Dec; 32(8):588-93. PubMed ID: 17008012
[TBL] [Abstract][Full Text] [Related]
19. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
[TBL] [Abstract][Full Text] [Related]
20. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
